Aristeia Capital LLC Ibere Pharmaceuticals Transaction History

Aristeia Capital LLC

  • $2.75 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$9.93 - $10.09 $2.48 Million - $2.52 Million
250,000 Added 58.8%
675,173 $6.81 Million
Q3 2022

Nov 14, 2022
BUY
$0.11 - $9.94 $8,250 - $745,500
75,000 Added 21.42%
425,173 $4.21 Million
Q2 2022

Aug 16, 2022
BUY
$9.77 - $9.84 $1,690 - $1,702
173 Added 0.05%
350,173 $3.44 Million
Q1 2022

May 16, 2022
BUY
$9.69 - $9.81 $3.39 Million - $3.43 Million
350,000 New
350,000 $3.43 Million

Others Institutions Holding IBER

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IBERE PHARMACEUTICALS

IBER Quotes by TradingView
  • Ticker IBER
  • Exchange NYSE
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,800,000
  • Description
  • Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
More about IBER
Track This Portfolio

Track Aristeia Capital LLC Portfolio

Follow Aristeia Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristeia Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristeia Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email